The current study determined the levels of WISP-2 expression in astrocytomas and normal brain tissues using reverse transcription (RT)-polymerase chain reaction (PCR) and immunohistochemistry. The gene discussed is CCN5; the disease is astrocytoma (excluding glioblastoma).